Logo Logo
Hilfe
Hilfe
Switch Language to English

Hepp, Paula; Unverdorben, Laura; Hutter, Stefan; Kuhn, Christina; Ditsch, Nina; Gross, Eva; Mahner, Sven; Jeschke, Udo; Knabl, Julia und Heidegger, Helene H. (2020): Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis. In: International Journal of Molecular Sciences, Bd. 21, Nr. 7, 2404

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Gestational diabetes mellitus (GDM) is the most common pregnancy-associated metabolic disorder that negatively impacts on the health of both mothers and their offspring in the long-term. The molecular mechanisms involved are not fully understood. As in other states of insulin resistance, a disproportionate immune response in GDM leads to a state of chronic low-grade inflammation. Galectin-2 exerts regulatory effects on different immune cells. This study investigated galectin-2 expression in the placenta of 40 GDM patients and 40 controls, in a sex-specific manner. Immunohistochemistry was used for semi-quantitative analysis of expression strength. The phenotypes of galectin-2 expressing cells were characterized through double immunofluorescence. We found a significant up-regulation of galectin-2 in the fetal syncytiotrophoblast, as well as in the maternal decidua of GDM placentas. Double staining showed a strong galectin-2 expression in extra villous trophoblast cells and fetal endothelial cells in GDM. These findings present the first systematic investigation of galectin-2 in GDM. The findings contribute to the emerging understanding of the role of immunomodulation and inflammation in GDM and of galectin-2 itself. This might also have implications for the long-term cardiovascular health of the offspring.

Dokument bearbeiten Dokument bearbeiten